Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › El Paso › NPI 1770536120
Hospital

El Paso Healthcare System LTD

El Paso Healthcare System LTD was paid $38.51M by Medicaid between Jan 2018 and Dec 2024, across 164 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.

33Billing provider infoEL PASO HEALTHCARE SYSTEM LTD
EL PASO, TX 79902
33aNPI1770536120assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$38.51M
24GClaims572,371
24DCodes billed164
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Texas

Rank by total paid#2 of 109
Median peer was paid$1.15M
This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201837,816$3.82M
201923,589$1.56M
202037,704$1.49M
202198,449$6.06M
2022147,838$9.47M
2023142,275$10.56M
2024incomplete84,700$5.55M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 38% 44,255 41,298 $14.60M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 38% 86,677 83,927 $14.60M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 8,523 8,361 $1.24M
80053 Comprehensive metabolic panel 1.9% 41,316 35,171 $734K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 2,676 2,553 $723K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.5% 3,674 3,323 $592K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 2,346 2,206 $452K
70450 Computed tomography, head or brain; without contrast material 1.2% 4,197 3,896 $451K
G0378 Hospital observation service, per hour 1.1% 1,360 1,102 $424K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 23,236 21,323 $415K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,863 1,734 $308K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,705 2,520 $285K
152 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,938 $272K
71045 Radiologic examination, chest; single view <1% 15,492 $256K
85027 <1% 49,433 $252K
71046 Radiologic examination, chest; 2 views <1% 3,540 $147K
81001 <1% 23,440 $128K
83690 <1% 10,893 $126K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,156 $119K
87070 <1% 14,885 $118K
84484 <1% 9,860 $109K
72125 Computed tomography, cervical spine; without contrast material <1% 1,074 $102K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,380 $89K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 16,164 $87K
96375 Therapeutic injection; each additional sequential IV push <1% 6,799 $85K
84702 <1% 2,459 $84K
87430 <1% 11,957 $83K
76801 <1% 829 $71K
96361 Intravenous infusion, hydration; each additional hour <1% 3,677 $70K
84703 <1% 4,199 $70K
36415 Collection of venous blood by venipuncture <1% 18,379 $66K
80048 Basic metabolic panel (calcium, ionized) <1% 3,677 $54K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 563 $51K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 788 $49K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 437 $48K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 307 $46K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,424 $46K
81025 <1% 2,394 $46K
73030 <1% 635 $38K
73562 <1% 775 $37K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,777 $34K
73610 <1% 484 $32K
74018 <1% 441 $31K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 555 $31K
90715 <1% 202 $29K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,076 $29K
93017 <1% 383 $28K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 359 $26K
76830 Ultrasound, transvaginal <1% 169 $25K
85730 <1% 4,185 $25K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,900 $25K
72100 <1% 347 $24K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 3,844 $24K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,720 $23K
85610 <1% 5,105 $23K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 636 $23K
87186 <1% 1,574 $21K
83880 <1% 2,391 $21K
80047 <1% 426 $21K
87040 <1% 1,566 $20K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 317 $19K
87077 <1% 1,966 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,889 $18K
73630 <1% 397 $17K
84443 Thyroid stimulating hormone (TSH) <1% 1,472 $17K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,975 $17K
86850 <1% 1,253 $16K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 335 $14K
86900 <1% 2,772 $13K
86901 <1% 2,774 $13K
81003 <1% 3,175 $13K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,890 $12K
73110 <1% 195 $12K
83605 <1% 1,930 $12K
71275 Computed tomographic angiography, chest, with contrast material <1% 136 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 357 $10K
83735 <1% 3,987 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 356 $10K
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,149 $9K
86756 <1% 820 $9K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 37 $8K
73130 <1% 158 $7K
80061 Lipid panel <1% 1,064 $7K
85014 <1% 438 $7K
82150 <1% 223 $6K
70486 <1% 49 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 1,167 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 658 $5K
84100 <1% 1,805 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,697 $4K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 123 $4K
93970 <1% 101 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 124 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 79 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,246 $4K
71250 <1% 52 $3K
96376 <1% 1,083 $3K
87420 <1% 176 $3K
93971 <1% 103 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,798 $3K
97163 <1% 293 $3K
83013 <1% 29 $3K
97167 <1% 281 $3K
72170 <1% 103 $2K
97116 <1% 136 $2K
82565 <1% 222 $2K
85379 <1% 312 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,224 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 13 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 199 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 42 $2K
86140 <1% 409 $2K
72131 <1% 29 $2K
C1769 Guide wire <1% 217 $2K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 527 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 12 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 29 $1K
73590 <1% 45 $1K
J2060 Injection, lorazepam, 2 mg <1% 433 $1K
12001 <1% 16 $1K
87276 <1% 1,164 $960.71
J1170 Injection, hydromorphone, up to 4 mg <1% 604 $951.12
87205 <1% 62 $885.78
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,231 $758.43
83970 <1% 56 $733.45
82140 <1% 33 $643.81
80197 <1% 358 $612.74
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 315 $592.41
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,108 $549.11
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,212 $509.39
73502 <1% 12 $470.34
A9270 Non-covered item or service <1% 4,160 $431.05
J1650 Injection, enoxaparin sodium, 10 mg <1% 128 $428.41
80143 <1% 59 $395.49
73090 <1% 14 $343.17
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 760 $338.90
83014 <1% 29 $317.45
J2704 Injection, propofol, 10 mg <1% 727 $287.25
84439 <1% 89 $259.44
82570 <1% 158 $254.93
J1815 Injection, insulin, per 5 units <1% 1,580 $233.74
J2550 Injection, promethazine hcl, up to 50 mg <1% 360 $228.82
J0690 Injection, cefazolin sodium, 500 mg <1% 94 $207.27
87210 <1% 39 $171.09
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 111 $169.86
82550 <1% 80 $168.24
J2785 Injection, regadenoson, 0.1 mg <1% 98 $130.53
87340 <1% 15 $127.96
J1630 Injection, haloperidol, up to 5 mg <1% 126 $112.16
J7050 Infusion, normal saline solution, 250 cc <1% 95 $101.08
84550 <1% 26 $95.01
85651 <1% 14 $92.75
84156 <1% 48 $78.59
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 402 $57.77
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 36 $57.40
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 122 $53.57
82607 <1% 15 $42.54
84520 <1% 21 $39.35
S0028 Injection, famotidine, 20 mg <1% 36 $34.62
82009 <1% 14 $31.36
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 40 $4.48
80076 0% 31 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 255 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGARVIN, MARIA (CFO)